CA2237335A1 - Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie - Google Patents

Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie

Info

Publication number
CA2237335A1
CA2237335A1 CA002237335A CA2237335A CA2237335A1 CA 2237335 A1 CA2237335 A1 CA 2237335A1 CA 002237335 A CA002237335 A CA 002237335A CA 2237335 A CA2237335 A CA 2237335A CA 2237335 A1 CA2237335 A1 CA 2237335A1
Authority
CA
Canada
Prior art keywords
xerostomia
treatment
cholinesterase inhibitors
cholinesterase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002237335A
Other languages
English (en)
Other versions
CA2237335C (fr
Inventor
Jorgen Ekstrom
Herbert Helander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALABAR AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9504267A external-priority patent/SE9504267D0/xx
Application filed by Individual filed Critical Individual
Publication of CA2237335A1 publication Critical patent/CA2237335A1/fr
Application granted granted Critical
Publication of CA2237335C publication Critical patent/CA2237335C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002237335A 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie Expired - Fee Related CA2237335C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9504267-7 1995-11-29
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use
PCT/SE1996/001531 WO1997019685A1 (fr) 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie

Publications (2)

Publication Number Publication Date
CA2237335A1 true CA2237335A1 (fr) 1997-06-05
CA2237335C CA2237335C (fr) 2007-06-05

Family

ID=38137603

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002237335A Expired - Fee Related CA2237335C (fr) 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie

Country Status (1)

Country Link
CA (1) CA2237335C (fr)

Also Published As

Publication number Publication date
CA2237335C (fr) 2007-06-05

Similar Documents

Publication Publication Date Title
CA2239174A1 (fr) Nouveaux composes a effet analgesique
CA2186039A1 (fr) Nouvelle forme galenique pharmaceutique orale
CA2274074A1 (fr) Nouveaux composes a effet analgesique
CA2173976A1 (fr) Phenylacetate et ses derives seuls ou associes a d'autres composes pour traiter des neoplasmes et d'autres troubles
CA2218714A1 (fr) Forme galenique contenant de l'oxybutynine
AU7224396A (en) Pharmaceutically active quinazoline compounds
EP1743630A3 (fr) Combinaison pharmaceutique
CA2125662A1 (fr) Systeme a administration transdermique contenant de l'acide acetylsalicylique pour le traitement de la thrombose et la prophylaxie du cancer
CA2179015A1 (fr) Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale
CA2158609A1 (fr) Inhibiteurs de la 5.alpha.-reductase
AU6698996A (en) A film for topical use in the treatment of wounds
AU6946491A (en) Orally active renin inhibitors
CA2190837A1 (fr) Administration transdermique de medicaments anti-epileptiques
AU1956092A (en) Pharmaceutical agent for treatment of withdrawal symptoms
EP0765661A3 (fr) Utilisation de l'acide docosahexaénique pour la fabrication d'un médicament pour le traitement de la glomérulonephrite
CA2158354A1 (fr) Utilisation de granisetron pour le traitement de nausees et de vomissements postoperatoires
HUP9901990A2 (en) Furan- and thiophene derivatives having inhibitor effect on the replication of hiv-1 and hiv-1 mutants, and medicaments containing the same
SE9504267D0 (sv) New therapeutic use
CA2120319A1 (fr) Compose pharmaceutique pour le traitement des dermatopathies
CA2235951A1 (fr) Nouveaux emplois du ctla-8 de mammifere et reactifs associes
CA2237335A1 (fr) Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU4179497A (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment f AIDS
CA2179634A1 (fr) Analgesiques a base de 4-arylisoindole
AU6355296A (en) Use of a non-nucleoside reverse transcriptase inhibitor in a ssociation with nucleoside inhibitors for the treatment of h iv infection

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed